Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort.
By T. Feldman, Saibal Kar, M. Rinaldi, P. Fail, J. Hermiller, R. Smalling, P. Whitlow, W. Gray, R. Low, H. Herrmann and 3 more. Journal of the American College of Cardiology, 2009
929 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/cd742f7f953435f9b899a6ae1419afd8c602be29
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
- Jeroen J. Bax
- Helmut Baumgartner
- Paulus Kirchhof
- Gerasimos Filippatos
- Frank Flachskampf
- Volkmar Falk
- Stephan Windecker
- B. K. Pedersen
Citations in the corpus
- Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. (2013, background): “Compared with early reports (5), length of stay was longer, likely reflective of baseline high-risk status and standard treatment practices in Europe.”
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 (2012, background): “In patients with an indication for valve repair but judged inoperable or at unacceptably high surgical risk, percutaneous edge-to-edge repair may be considered in order to improve symptoms.(250)”